We are pleased to announce that Dr. Emily Levitan, a Professor at the UAB School of Public Health, has been appointed as a Co-Principal Investigator for the UAB Multicenter AIDS Cohort Study/Women’s Interagency HIV Study (MWCCS). Dr. Levitan joins Dr. Mirjam-Colette Kempf in this leadership role, bringing a wealth of expertise and dedication to our research initiative.
Dr. Levitan received her Doctoral training at Harvard’s School of Public Health. She became a part of the UAB family in 2009. Her contributions to epidemiology and public health have been widely recognized, making her an invaluable addition to our team. Her primary commitment is to improve public health through population research using traditional epidemiologic studies and administrative data with an emphasis on cardiovascular disease and the long-term effects of HIV and COVID-19. Dr. Levitan’s research projects also focus on the primary and secondary prevention of heart failure and other cardiovascular diseases. She is co-PI of numerous cohort including REGARDS-MI, which is a longitudinal study evaluating cardiovascular disease incidence and outcomes in this diverse nationwide cohort, and the Deep South SARS-CoV-2 Recovery Cohort, one of the cohorts of adults contributing to the NIH RECOVER Initiative which examine the effects of long COVID.
Together with Dr. Kempf, Dr. Levitan will play a pivotal role in advancing the objectives of the UAB MWCCS, focusing on the study’s scientific initiatives. Their collaborative efforts promise to enhance our understanding of the focus of HIV/AIDS and its impact on public health outcomes.
Please join me in welcoming Dr. Emily Levitan to her new role as Co-Principal Investigator of the UAB MWCCS. We look forward to her leadership and contributions to achieving our research goals.
